Inhalation Sciences: Rights issue announcement

Research Note

2023-04-06

11:15

Redeye comments on ISAB’s rights issue announcement of approximately SEK17.1m before issue-related costs. The subscription price is set to SEK3.6, corresponding to a c31% discount compared to yesterday’s closing price. Moreover, the issue is guaranteed up to 80% by subscription commitments (c10.4%) and guarantee commitments (c69.6%). We had already included an assumed rights issue in our valuation; however, we will not adjust our model before the outcome in May.

GM

Gustaf Meyer

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.